Skip to main content
PolicySpeak
← All files
FCI

Fachverband der Chemischen Industrie Österreichs

Industry association · Austria · EU Transparency Register 01523296397-60

3
positions filed
in the 326 files tracked
3
legislative files
of 326 tracked
0
with a full position paper
attached to a submission

Counts here are a floor, never a total: they cover the 326 consultation files tracked so far (29,503 submissions, mostly 2025–26), so an organization's real filing history is larger, not smaller.

Who they are

Among the 1205 trade and business associations on this site, they rank #538 by legislative files engaged — a count of participation, not a measure of influence.

2.6
declared lobbying FTE
self-declared
€400K+
declared costs / yr (floor)
0
EP accreditations
as declared to the register
2011
in the register since

Declares membership of

Self-declared to the EU Transparency Register (snapshot 30 Aug 2026).

Register category
Trade and business associations
Head office
Wien, Austria

Self-declared to the EU Transparency Register (snapshot 30 Aug 2026); cost bands are floors, not audited totals. Reused under Commission Decision 2011/833/EU.

Track Fachverband in PolicySpeak: request access →

Work at Fachverband der Chemischen Industrie Österreichs? so we know who speaks for it.

Follow the files Fachverband der Chemischen Industrie Österreichs engages with

One email on Tuesdays when a new position is filed on these 3 files, from Fachverband der Chemischen Industrie Österreichs or from anyone else on them. Only when there is something new.

We use your email for these updates, and PolicySpeak may contact you about the product. Unsubscribe in one click. Privacy policy.

Their record over time

Fachverband der Chemischen Industrie Österreichs filed 3 positions between 4 Mar 2026 and 5 Aug 2026, across 3 of the 326 legislative files tracked here.

What they argued

European Biotech Actfiled 5 Aug 2026source

The Association welcomes the European Biotech Act I and strongly supports the objective of making Europe the world’s most attractive location for research, development, clinical trials, manufacturing and scaling of biotech innovations. It is crucial to create a coherent, reliable and internationally competitive framework along the entire value chain.

Filed in German · English published by the European Commission

Biotech Act IIfiled 10 Jun 2026source

The FCIO warmly welcomes the Commission’s initiative on a Biotech Act II. The Biotech Act II should be designed as an ambitious, growth- and market-oriented EU framework for relevant knowledge giants, industrial bioeconomy and biotechnological production processes. The aim must be to translate scientific excellence into industrial value creation, employment and sustainable solutions.

Filed in German · English published by the European Commission

Evaluation of the Biocidal Products Regulationfiled 4 Mar 2026source

FCIO supports a targeted and comprehensive reform of the Biocidal Products Regulation to ensure the harmonisation of the internal market and the availability of effective biocidal products in Europe. High regulatory requirements, lengthy procedures and significant uncertainties in permitting and authorisation processes place a heavy burden on businesses.

Filed in German · English published by the European Commission

Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.

Turns up on the same files

Organizations that also filed on at least two of the same consultations. A shared interest in the same dossiers — not evidence of coordination, and we do not suggest any.

Showing 5 of 88.

Is this your organization?

Everything on this page comes from Fachverband der Chemischen Industrie Österreichs’s own submissions to the European Commission — we have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.

Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.